Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors

International Journal of Cancer

Volumn 79, Issue 4, 1998, Pages 376-383

  Norberg, Torbjörn ^a   Lennerstrand, Johan ^a,b   Inganas, Mats ^c   Bergh, Jonas ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b AB Sangtec Medical   (Sweden)

^c GE Healthcare Bio Sciences AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL;

BREAST NEOPLASMS; DNA, COMPLEMENTARY; GENES, P53; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MUTATION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031856995     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980821)79:4<376::AID-IJC12>3.0.CO;2-3     Document Type: Article

References (26)

1. AAS, T., BLRRESEN, A.L., GEISLER S., SMITH-SORENSEN B., JOHNSEN H., VARHAUG J.E., AKSLEN L.A. and LONNING PE., Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature (Med.), 2, 811-814 (1996).
2. ALLRED D.C., CLARK G.M., ELLEDGE R., FUQUA S.A., BROWN R.W., CHAMNESS G.C., OSBORNE C.K. and MCGUIRE W.L., Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. nat. Cancer Inst. 85, 200-206 (1993).
3. ARMITAGE, P. and BERRY, G., Statistical methods in medical research (3rd ed.), p. 331, Blackwell, Oxford (1994).
4. BANKS, L., MATLASHEWSKI, G. and CRAWFORD L., Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Europ. J. Biochem. 159, 529-534 (1986).
5. BERGH, J., NORBERG, T., SJÖGREN, S., LINDGREN, A. and HOLMBERG L., Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature (Med.) 1, 1029-1034 (1995).
6. BORG, Å., LENNERSTRAND, J., S10MARK-ASKMALM, M., FERNO, M., BRISFORS, A., OHRVIK, A., STAL, O., KILLANDER, D., LANE, D. and BRUNDELL, J., Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols. Brit. J. Cancer 71, 1013-1017 (1995).
7. BØRRESEN, A.L. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer, 14, 71-75 (1995).
8. CHO, Y., GORINA, S., JEFFREY, P.D. and PAVLETICH N.P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
9. COLES, C., THOMPSON, A.M., ELDER, P.A., COHEN B.B., MACKENZIE, I.M., CRANSTON, G., CHETTY, U., MACKAY, J., MACDONALD, M., NAKAMURA, Y., HOYHEIM, B. and STEEL, CM., Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336, 761-763 (1990).
10. CUNNINGHAM, J., LUST, J.A., SCHAID, D.J., BREN, G.D., CARPENTER, H.A., RIZZA, E., KOVACH, J.S. and THIBODEAU, SN., Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res., 52, 1974-1980 (1992).
11. DAVIDOFF, A.M., KERNS, B.J., PENCE, J.C., MARKS, J.R. and IGLEHART, JD., p53 alterations in all stages of breast cancer. J. Surg. Oncol., 48, 260-267 (1991).
12. DE WITTE, H.H., FOEKENS, J.A., LENNERSTRAND, J., SMID, M., LOOK M.P., KLIJN, J.G., BENRAAD, T.J. and BERNS, E.M., Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis. Int. J. Cancer, 69, 125-130 (1996).
13. ELLEDGE, RM., Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick? J. nat. Cancer Inst. 88, 141-143 (1996).
14. HARRIS, C., Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. nat. Cancer Inst., 88, 1442-1455 (1996).
15. HAUPT, Y., MAYA, R., KAZAZ, A. and OREN, M., Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387, 296-299 (1997).
16. IGGO, R., GATTER, K., BARTEK, J., LANE, D. and HARRIS, A.L., Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675-679 (1990).
17. ISOLA, J., VISAKORPI, T., HOLLI, K. and KALLIONIEMI, O.P., Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J. nat. Cancer Inst., 84, 1109-1114 (1992).
18. KUBBUTAT, M.H., J1s, S.N. and VOUSDEN, K.H., Regulation of p53 stability by Mdm2. Nature (Lond.), 387, 299-303 (1997).
19. LANE, D.P., LU, X., HUPP, T. and HALL, P.A., The role of the p53 protein in the apoptotic response. Phil. Trans. Roy. Soc. (Lond.) B. Biol. Sci., 345, 277-280 (1994).
20. MACGEOCH, C., TURNER, G., BOBROW, L.G., BARNES, D.M., BISHOP, D.T. and SPURR, N.K., Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining. J. med. Genet., 32, 186-190 (1995).
21. SILVESTRINI, R., VENERONI, S., BENINI, E., DAID1, M.G., LUISI, A., LEUTNER, M., MAUCI1, A., KENDA, R., ZUCALI, R. and VER1SI, U., Expression of p53, glutathil S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J. nat. Cancer Inst., 89, 639-645 (1997).
22. SJÖGREN, S., INGANÄS, M., NORBERG, T., LINDGREN, A., NORDGREN, H., HOLMBERG, L. and BERUH, J., The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. nat. Cancer Inst., 88, 173-182 (1996).
23. STEPHEN, C.W., HELMINEN, P. and LANE, D.P., Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. J. mol. Biol., 248, 58-78 (1995).
24. THOR, A.D., MOORE, D.H II, EDGERTON, S.M., KAWASAKI, E.S., REIHSAUS, E., LYNCH, H.T., MARCUS, J.N., SCHWARTZ, L., CHEN L.C., MAYALL, B.H. and SMITH, H.S., Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. nat. Cancer Inst., 84, 845-855 (1992).
25. THUT, C.J., GOODRICH, J.A. and TJIAN, R., Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Development, 11, 1974-1986 (1997).
26. VOJTESEK, B., BARTER, J., MIDGLEY, C.A. and LANE, D.P., An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. immunol. Methods, 151, 237-244 (1992).